Skip to main content

STIFEL FINANCIAL CORP

Position in NVO — Novo Nordisk A S

CIK 720672 ST. LOUIS, MO

Position in NVO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$71,695,082
+$29,194,406 QoQ
Shares Held
1,495,517
+29.3% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#44
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

STIFEL FINANCIAL CORP holds $5,426,093,696 across 17 Drug Manufacturers - General names. NVO ranks #10 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $71,695,082 1,495,517
2026-03-31 $42,500,676 1,156,481
2025-12-31 $64,500,574 1,267,700
2025-09-30 $51,015,949 919,372
2025-06-30 $79,162,416 1,146,949
2025-03-31 $82,461,177 1,187,517
2024-12-31 $130,506,702 1,517,167
2024-09-30 $209,240,517 1,757,290
2024-06-30 $252,939,844 1,772,032
2024-03-31 $217,935,372 1,697,316
2023-12-31 $168,119,385 1,625,127
2023-09-30 $138,724,420 1,525,450
2023-06-30 $120,618,369 745,340
2023-03-31 $159,591,797 1,002,839
2022-12-31 $163,681,817 1,209,412
2022-09-30 $121,754,531 1,222,067
2022-06-30 $138,155,925 1,239,845
2022-03-31 $130,226,443 1,172,683
2021-12-31 $116,792,368 1,042,789
2021-09-30 $97,237,101 1,012,781
2021-06-30 $81,305,652 970,582
2021-03-31 $63,052,934 935,226
2020-12-31 $55,979,672 801,427
2020-09-30 $53,968,076 777,302
2020-06-30 $50,081,393 764,835
2020-03-31 $24,828,164 412,428